Mangalam Drugs & Organics Limited (BSE:532637) agreed to acquire Shri JB Pharma LLP on March 15, 2024. The consideration consists of 265 equity shares of Mangalam Drugs & Organics Limited to be issued for common equity of Shri JB Pharma LLP. The Scheme is subject to the necessary statutory and regulatory approvals including the approvals of National Company Law Tribunal, the shareholders and creditors of Mangalam Drugs & Organics Limited and Shri JB Pharma Private Limited.

The transaction has been approved by the Borad of Directors of Mangalam Drugs & Organics Limited.